PFIZER TO INVEST $200 MILLION IN CHINESE PHARMA COMPANY CSTONE

Highlights

• According to the statement issued by Chinese pharmaceutical company, it will receive up to $280 million in payments for sugemalimab, and additional royalties

• As per the deal, the world’s second-largest pharmaceutical company has agreed to purchase 115.93 million CStone shares at a price of $1.725 per share

• The statement said that both the companies will develop and commerciali....